Federal Update: Trump Administration Demands Manufacturers Take Action on Most-Favored-Nation Pricing Scheme | AMCP.org
AMCP comments on Trump Administration demands for manufacturers to take action on Most-Favored-Nation pricing scheme
AMCP comments on Trump Administration demands for manufacturers to take action on Most-Favored-Nation pricing scheme
The AMCP Foundation offers variety of awards and immersive learning opportunities. Here, you can submit an application, nomination, supporting letters and other materials for the…
Just after midnight on the morning of Aug. 7, President Trump’s sweeping “reciprocal” tariffs took effect on dozens of international trading partners, marking another dramatic…
In both of his administrations, President Trump promoted most-favored nation (MFN) pricing as a way to bring down drug costs in the United States. On…
In a recent study by Mercer, 77% of employers named the management of GLP-1 costs as their top health-benefit issue.
In this episode of Unscripted, AMCP speaks with Dr. Harrison Nguyen, a double board-certified dermatologist and health economist, about the true scope of psoriasis. From…
AMCP comments on Trump Administration demands for manufacturers to take action on Most-Favored-Nation pricing scheme
Get to Know AMCP Foundation’s 2025 Summer Interns. These aspiring pharmacists are embarking on a valuable journey of gaining practical experience through our internships at…
The inaugural AMCP Pharmacy Policy Summit w ill be held on October 27, 2025, and will bring leading health policy experts together to discuss critical…
The AMCP Foundation offers variety of awards and immersive learning opportunities. Here, you can submit an application, nomination, supporting letters and other materials for the…